Frontiers in Bioengineering and Biotechnology (Apr 2021)

Association Between Finger-to-Nose Kinematics and Upper Extremity Motor Function in Subacute Stroke: A Principal Component Analysis

  • Ze-Jian Chen,
  • Ze-Jian Chen,
  • Chang He,
  • Nan Xia,
  • Nan Xia,
  • Ming-Hui Gu,
  • Ming-Hui Gu,
  • Yang-An Li,
  • Yang-An Li,
  • Cai-Hua Xiong,
  • Jiang Xu,
  • Jiang Xu,
  • Xiao-Lin Huang,
  • Xiao-Lin Huang

DOI
https://doi.org/10.3389/fbioe.2021.660015
Journal volume & issue
Vol. 9

Abstract

Read online

BackgroundKinematic analysis facilitates interpreting the extent and mechanisms of motor restoration after stroke. This study was aimed to explore the kinematic components of finger-to-nose test obtained from principal component analysis (PCA) and the associations with upper extremity (UE) motor function in subacute stroke survivors.MethodsThirty-seven individuals with subacute stroke and twenty healthy adults participated in the study. Six kinematic metrics during finger-to-nose task (FNT) were utilized to perform PCA. Clinical assessments for stroke participants included the Fugl-Meyer Assessment for Upper Extremity (FMA-UE), Action Research Arm Test (ARAT), and Modified Barthel Index (MBI).ResultsThree principal components (PC) accounting for 91.3% variance were included in multivariable regression models. PC1 (48.8%) was dominated by mean velocity, peak velocity, number of movement units (NMU) and normalized integrated jerk (NIJ). PC2 (31.1%) described percentage of time to peak velocity and movement time. PC3 (11.4%) profiled percentage of time to peak velocity. The variance explained by principal component regression in FMA-UE (R2 = 0.71) were higher than ARAT (R2 = 0.59) and MBI (R2 = 0.29) for stroke individuals.ConclusionKinematic components during finger-to-nose test identified by PCA are associated with UE motor function in subacute stroke. PCA reveals the intrinsic association among kinematic metrics, which may add value to UE assessment and future intervention targeted for kinematic components for stroke individuals.Clinical Trial RegistrationChinese Clinical Trial Registry (http://www.chictr.org.cn/) on 17 October 2019, identifier: ChiCTR1900026656.

Keywords